Published in Obesity and Diabetes Week, September 11th, 2006
"Postprandial lipid abnormalities might contribute to the excess of cardiovascular risk typical of type 2 diabetic patients. The study evaluated the effects of atorvastatin (20 mg/d) vs. fenofibrate (200 mg/d) on postprandial lipids in type 2 diabetic patients with mixed hyperlipidaemia," scientists writing in the European Journal of Clinical Investigation report.
C. Iovine and colleagues at the University of Naples Federico II described, "Eight type 2 diabetic patients, male/female (M/F) 6/2, age...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week